Table 1 Clinical characteristics of the 26 ovarian cancer patients with brain metastasis
From: Prognostic impact of platinum sensitivity in ovarian carcinoma patients with brain metastasis
Characteristic | Freq. (%) |
|---|---|
Age (median / IQR) | 63.0 (54.1–65.7) |
Family history | |
Present | 5 (19.2) |
Absent | 19 (73.1) |
Unknown | 2 (7.7) |
Histology | |
High grade serous | 17 (65.4) |
Endometrioid | 2 (7.7) |
Undifferentiated | 2 (7.7) |
Carcinossarcoma | 1 (3.8) |
Mixed | 1 (3.8) |
Unknown | 3 (11.5) |
FIGO stage | |
I-III | 20 (76.9) |
IV | 5 (19.2) |
Unknown | 1 (3.8) |
ECOG performance status | |
0 | 4(15.4) |
1 | 12 (46.2) |
2 | 2 (7.7) |
3 | 3 (11.5) |
Unknown | 5 (19.2) |
Residue disease after first surgery | |
> 1 cm | 18 (69.2) |
< 1 cm | 5 (19.2) |
Unknown | 3 (11.5) |